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Background: Batch effects in DNA methylation microarray experiments can lead to
spurious results if not properly handled during the plating of samples.
Methods: Two pilot studies examining the association of DNAmethylation patterns across
the genome with obesity in Samoan men were investigated for chip- and row-specific
batch effects. For each study, the DNA of 46 obese men and 46 lean men were assayed
using Illumina’s Infinium HumanMethylation450 BeadChip. In the first study (Sample One),
samples from obese and lean subjects were examined on separate chips. In the second
study (Sample Two), the samples were balanced on the chips by lean/obese status, age
group, and census region. We used methylumi, watermelon, and limma R packages, as
well as ComBat, to analyze the data. Principal component analysis and linear regression
were, respectively, employed to identify the top principal components and to test for their
association with the batches and lean/obese status. To identify differentially methylated
positions (DMPs) between obese and lean males at each locus, we used a moderated
t-test.
Results: Chip effects were effectively removed from Sample Two but not Sample One.
In addition, dramatic differences were observed between the two sets of DMP results.
After “removing” batch effects with ComBat, Sample One had 94,191 probes differentially
methylated at a q-value threshold of 0.05 while Sample Two had zero differentially
methylated probes. The disparate results from Sample One and Sample Two likely arise
due to the confounding of lean/obese status with chip and row batch effects.
Conclusion: Even the best possible statistical adjustments for batch effects may not
completely remove them. Proper study design is vital for guarding against spurious
findings due to such effects.
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INTRODUCTION
DNAmethylation is a vital type of epigenetic modification which
usually occurs in CpG-rich regions in mammals and is involved
in regulating gene expression and silencing (Selaru et al., 2009;
Sharma et al., 2010). Altered methylation levels, such as those
due to environmental factors and lifestyle, may play a role in
a variety of disease processes. For instance, many studies have
revealed association of aberrant DNA methylation with diseases
such as cancers (Karpin´ski et al., 2008; Feinberg and Irizarry,
2010; Hansen et al., 2011), obesity (Feinberg et al., 2010; Wang
et al., 2010; Xu et al., 2013; Dick et al., 2014), and rheumatoid
arthritis (Liu et al., 2013). High-throughput technologies, such
as microarray and sequencing-based DNA methylation profil-
ing, have been developed to facilitate the investigation of gene
expression, gene regulation, and epigenetic interactions between
cells and environment.
The Infinium HumanMethylation450 BeadChip (Illumina,
San Diego, CA) is one of the most commonly used epigenome-
wide methylation profiling platforms. It covers 99% of RefSeq
genes and 96% of CpG islands, with additional coverage in island
shores and the regions flanking them. This technology interro-
gates more than 485,000 methylation sites per sample, and each
chip can accommodate 12 samples in a 2 column by 6 rowmatrix.
Thus, samples in large studies are often assayed across many dif-
ferent individual chips processed at different times, which may
result in batch effects (Johnson et al., 2007; Leek et al., 2010; Sun
et al., 2011; Yan et al., 2012; Harper et al., 2013). Batch effects
are non-biological variations that are related to experimental
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factors, such as laboratory conditions, experiment time, reagent
lots, laboratory personnel differences, and chip position. Batch
effects are a major problem when they are correlated with the
outcome or predictors of interest. Without appropriate correc-
tion measures, batch effects may lead to inaccurate conclusions
(false positives) or increased variability and significant reduction
in power to detect true biological signals (Baggerly et al., 2004;
Akey et al., 2007; Leek and Storey, 2007). Moreover, undetected
batch effects can lead to substantial misallocation of resources
and lack of reproducibility (Baggerly et al., 2008). Batch effects
that affect different probes in different ways cannot be removed
by normalization methods that adjust for global properties of
measurements. Special techniques like ComBat (Johnson et al.,
2007) are employed to adjust for batch effects; however, their
effectiveness depends on the study design. Although batch effects
cannot be fully eliminated from even a perfectly designed study,
Hu et al. (2005) stressed that the key step to addressing batch
effects and other technical artifacts in high-throughput data is
careful study design. In a case–control study, the cases and con-
trols should be equally distributed across the factors considered to
be a batch effect (Hu et al., 2005). For example, Liu et al. (2013)
found an unanticipated association between their methylation
data and assay date, which was the result of an unbalanced distri-
bution of cases and controls across those dates. Similarly, Harper
et al. (2013) found that when samples are not randomized across
chips, then even powerful techniques like ComBat could not fully
remove the batch effects, hence leading to an excess of apparently
differentially methylated probes. However, randomization does
not ensure equal allocation of cases and controls across the chips,
especially with small samples.
In this study, we present the findings of two pilot studies
examining DNA methylation profiles in Samoan obese and lean
young male adults to illustrate how chip-specific effects can lead
to spurious results when an unbalanced study design is employed
during the plating of samples.
WHY TWO PILOT STUDIES?
The original objective of the first pilot study (Sample One) was
to examine DNA methylation patterns across the genome in 46
obese and 46 lean male Samoans to identify epigenetic loci asso-
ciated with obesity. We carried out standard quality control steps.
When we examined box plots of raw and normalized β-values for
each participant ordered by chip position, we observed patterns
that suggested chip and row effects, and we tried to remove those
batch effects using ComBat. To determine whether the adjust-
ment worked, we examined plots of the technical replicates, and
the agreements in values between the replicates seemed to show
that ComBat had indeed removed the batch effects. Therefore, we
moved ahead and tested for probes that were differentially methy-
lated between the lean and obese individuals. The results seemed
promising, and hence an abstract was written and accepted for
presentation at the 2013 meeting of the American Society of
Human Genetics (Buhule et al., 2013).
However, we were concerned about the apparent excess of
significant probes and uncomfortable with how the samples
had been arrayed on the chips in Sample One (upper panel
of Figure 1). To assess whether the layout of samples might
have had an effect on our results—one that could not be
removed by ComBat—and to attempt to replicate the differ-
entially methylation probes from Sample One, we performed a
second pilot study (Sample Two). As in Sample One, 46 lean
and 46 obese Samoan men were examined. The samples were
carefully balanced across the chips to avoid confounding the out-
come and predictor variables with the layout (lower panel of
FIGURE 1 | Chip layout in Sample One (unbalanced) and Sample Two (balanced); green and red represent lean and obese, respectively.
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Figure 1). We followed the same analysis steps as in the first pilot
study.
MATERIALS AND METHODS
SAMPLE COLLECTION AND DNA EXTRACTION
Two sets of 92 young (25–40 years) males each were
drawn, using stratified sampling by census region, from
the same Samoan population. This represents a subsample
from our larger genome-wide association study of adiposity-
related traits, the design of which is described in Hawley
et al. (2014). The informed consent and research protocols
were approved by both the Brown University Institutional
Review Board (protocol #0903992671) and the Health Research
Committee of the Samoan Ministry of Health. The demo-
graphic characteristics of the two sets are summarized in Table 1.
For each set, DNA was extracted from the peripheral whole
blood of 46 obese (body mass index ≥ 32 kg/m2 and abdom-
inal circumference ≥ 92.5 cm) and 46 lean (body mass
index < 26 kg/m2 and abdominal circumference < 92.5 cm)
Samoan males. The threshold of 92.5 cm was chosen because it
was the overall sample median for waist circumference among
this age group. As Table 1 shows, while both Samples have mean
ages in the 30’s, Sample Two has a lower mean age than Sample
One, both in the lean group (t-test p-value 0.003; Cohen’s d effect
size 0.64) and in the obese group (p-value 0.005; effect size 0.60);
comparing the obese men, Sample Two also has a lower mean
BMI (p-value 0.033; effect size 0.46) and abdominal circumfer-
ence (p-value 0.005; effect size 0.61) than Sample One (Cohen,
1992).
Blood was drawn while fasting the morning after anthro-
pometric measures were taken. Methylation levels were assayed
using the Infinium HumanMethylation450 BeadChip array
(Illumina, San Diego, CA) at the Genomics, Epigenomics and
Sequencing Core at the University of Cincinnati. For each sam-
ple, a total of 0.5–1µg intact genomic DNA as measured by
Qubit fluorometer (Lifetech, Grand Island, NY) was bisulfite
modified by using Zymo EZ DNA methylation kit (Irvine, CA).
The Illumina recommended incubation protocol (16 cycles of
95◦C for 30 s, 50◦C for 60min) was used for the DNA bisul-
fite conversion. Methylated cytosine in a CpG site resists bisuflite
modification and remains cytosine. In contrast, unmethylated
Table 1 | Study sample demographics.
Variable Sample One Sample Two
Lean Obese Lean Obese
n = 46 n = 46 n = 46 n = 46
Age (years), x¯ (s) 33.4 (4.1) 35.0 (3.6) 30.5 (4.9) 32.5 (4.5)
BMI (kg/m2), x¯ (s) 24.2 (1.4) 37.0 (5.2) 24.3 (1.3) 35.1 (2.6)
Abd. Circumf. (cm), x¯ (s) 81.9 (4.5) 113.2 (12.7) 81.0 (4.0) 107.1 (6.4)
CENSUS REGIONS
Apia, n (%) 9 (19.5) 9 (19.6) 9 (19.6) 13 (28.3)
NW Upolu, n (%) 15 (32.6) 15 (32.6) 15 (32.6) 16 (34.8)
Rest of Upolu, n (%) 12 (26.1) 12 (26.1) 12 (26.1) 14 (30.4)
Savai‘i, n (%) 10 (21.7) 10 (21.7) 10 (21.7) 3 (6.5)
cytosine is modified to uracil and converted to thymine in the
subsequent amplification step.
Using Infinium HumanMethylation450 BeadChip kit, the
bisulfite converted DNA is then denatured, isothermally ampli-
fied, enzymatically fragmented, and purified by precipitation. The
resuspended DNA fragments were hybridized onto the chip with
the beads attached to specific probes. After washing, a single-
base extension to differentiate methylated cytosine (still cytosine)
and unmethylated cytosine (converted to thymine) followed by
staining of the BeadChip were performed. The cy5/cy3-stained
FIGURE 2 | 450K methylation array data analysis pipeline.
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BeadChip was then coating-protected and scanned on Illumina
iSCAN to generate methylation raw data.
Figure 1 displays the layout of samples on different chips for
the two data sets as well as the locations of eight samples techni-
cally replicated in pairs (R1–R8). In the first pilot study (Sample
One), samples were “lumped together”—that is, the obese were
plated first, then the lean, and lastly the technical replicates
(Upper panel of Figure 1). For the second pilot study (Sample
Two), the samples were balanced by lean/obese status across chips
and rows (Lower panel of Figure 1). Additionally samples were
arranged so that each chip carried the same proportion of par-
ticipants from each Samoa census region and an equal number
above and below themedian age. This design shouldminimize the
probability of confounding between biological and batch effects.
STATISTICAL ANALYSES
For both data sets, we followed same steps (Figure 2), using
methylumi (Davis et al., 2013) and wateRmelon (Pidsley et al.,
2013) R packages to analyze the data from the 450K Human
Methylation Arrays. The raw ∗.idat files were imported into R
using the methylumIDAT() function from the methylumi pack-
age. For each data set, we excluded 65 SNP-containing probes
that do not interrogate methylation and 15,524 probes associ-
ated with frequent SNPs using the East Asian (ASN) list from
Touleimat and Tost’s pipeline (Touleimat and Tost, 2012). We
used East Asians because they represent the available population
most similar to Samoans. We then performed filtering using the
wateRmelon package to exclude any probes which have detec-
tion p-values > 0.01 in more than 10% of the samples or bead
counts < 3 in more than 5% of samples. Samples with detec-
tion p-values > 0.01 in more than 10% of the probes would also
have been excluded, but none met this threshold. Next, quantile
normalization, which adjusts for background differences between
Type I and Type II probes and does between-array normalization
to these probes separately with no dye bias correction (DASEN),
was performed. DASEN improves the ability to detect differen-
tially methylated sites because Type I and Type II probes are
known to perform differently (Pidsley et al., 2013). TheM-values(
log2
(
β
1−β
))
were then computed, where β-value is the ratio of
the methylated probe intensity and the total signal intensity.
To identify any technical differences that may be emanating
from a subset of samples or from sources not accounted for by
quantile normalization—that is, batch effects—we examined box
plots of the raw and normalized methylation values ordered by
chip position to identify patterns in the data.We then adjusted the
data for the chip and row batch effects using ComBat (Johnson
et al., 2007). This method uses a parametric empirical Bayes
framework to adjust data for batch effects and is robust to outliers
FIGURE 3 | Box plots of raw β-values by chip position; each color represents a chip.
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in small sample sizes. ComBat was applied to M-values as these
are preferred to β-values because β-values have been shown to
have a non-constant variance (Du et al., 2010).
To determine whether ComBat reduced technical variation
and effectively removed batch effects, first we examined plots
of technical replicates. In particular, we calculated the average
absolute differences in raw, pre- and post-ComBat normalized
M-values, examined box plots of the raw, pre- and post-ComBat
normalized M-values, and performed multidimensional scaling
(MDS) and hierarchical clustering of the pre- and post-ComBat
M-values. Secondly, principal component analysis (PCA) was
performed on all samples to determine the top four principal
components (PCs) present in the pre- and post-ComBat M-
values. We tested for association between each PC and chip, row,
or obese/lean group using linear regression.
To identify differentially methylated probes, we carried out
analyses using the limma package (Smyth, 2005). Limma uses an
empirical Bayes method to moderate the standard errors of the
estimated log-fold changes. This leads to more stable inference
and improved power because there is borrowing of strength from
the body of probes when making inference about each individ-
ual probe (Smyth, 2004). Hence, the statistic used is called the
moderated t-statistic, which was computed for each probe and
then adjusted for multiple testing using the Benjamini-Hochberg
FIGURE 5 | Mean of absolute difference inM-values between four
replicate pairs: the left and right panels represent Samples One and
Two, respectively.
FIGURE 4 | Box plots of DASEN transformed β-values by chip position; each color represents a chip.
www.frontiersin.org October 2014 | Volume 5 | Article 354 | 5
Buhule et al. Caution: 450K methylation batch effects
FIGURE 6 | Box plots of raw and transformedM-values for the four replicate pairs: upper and lower panels represent Samples One and Two,
respectively, and each color represents a replicate pair.
method (Benjamini and Hochberg, 1997). The analysis was per-
formed on both pre- and post-ComBatM-values.
RESULTS
EXPLORATORY ANALYSES
The box plots of the β-values of raw and DASEN-transformed
data from the two pipelines are presented in Figures 3, 4, respec-
tively. The results in Figure 3 indicate a time-series–like trend
of methylation levels (β-values) across and within the chips. In
particular, the methylation levels increased from first row to sixth
row within each chip. Normalization seem to have made this pat-
tern less noticeable (Figure 4). Even though the batch effects are
not as visually apparent, they still could be present, and indeed
are as we will see below.
The results in Figures 5, 6 showed that DASEN normaliza-
tion followed by adjustment, using ComBat, for chip and row
effects lead to greater reduction in variability among the technical
replicates. Furthermore, the MDS plots (Figure 7) and the hierar-
chical clustering trees (Figure 8) both indicated correct and closer
pairing of the technical replicates after ComBat.
The PCA results in Figure 9 indicated that ComBat effectively
removed row effects but not chip effects in Sample One. Before
adjusting for chip and row effects using ComBat, the fourth and
the first PCs were, respectively, significantly associated with chip
and row (p < 0.001). The fourth PC was also significantly asso-
ciated with the outcome variable (lean/obese status) (p < 0.001).
After using ComBat, the second and third PCs were significantly
associated with chip effects (p < 0.001) but no PCs were associ-
ated with row effects. The second and third PCs were also signif-
icantly associated with the outcome variable (p < 0.001). Thus,
ComBat increased the number of PCs significantly associated
with the chip batch and the outcome variable.
In contrast to Sample One, ComBat was able to effectively
remove the chip effect in the balanced Sample Two (left panel of
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FIGURE 7 | Multidimensional scaling plots of technical replicates pre-ComBat (top row) and post-ComBat (bottom row). Duplicates are most closely
correctly paired post-ComBat in both samples.
Figure 9). Before ComBat, the second, third, and fourth PCs were
significantly associated with the chip batch at p-values < 0.05,
< 0.001, < 0.001, respectively. After ComBat, no PC was found
to be significantly associated with the chip batch. The row batch
and the outcome variable were not significantly associated with
any of the PCs before and after using ComBat.
DIFFERENTIAL METHYLATION ANALYSIS
A total of 469,507 (Sample One) and 469,328 (Sample Two) CpG
loci across the genome were tested in two sets of 92 individu-
als (excluding duplicates). For Sample One, a total of 25,650 and
94,191 probes emerged as differentially methylated when using
the Pre-ComBat and Post-ComBat M-values, respectively, at an
q-value threshold of 0.05 (Table 2). In addition, 369 of 25,650
and 3660 of 94,191 probes had p-values less than the Bonferroni
threshold of 1.06 × 10−7. In marked contrast, Sample Two had
zero differentially methylated probes between the obese and lean
males when using either the Pre-ComBat or the Post-ComBat
M-values (Table 2).
DISCUSSION
Batch effects in high-throughput experiments that include but
are not limited to chip position and run dates are a common
and powerful source of variation in DNA methylation arrays.
When these batch effects are confounded with the variables of
interest, they can lead to inaccurate conclusions. In this study,
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FIGURE 8 | Hierarchical clustering of technical replicates pre-ComBat (top row) and post-ComBat (bottom row). Duplicates are correctly paired
post-ComBat in both samples.
we examined the impact of batch effects, in particular the chip
and row in which the samples were assayed, on the number of
differentially methylated probes when the study design is flawed.
We had two study groups (Sample One and Sample Two) sam-
pled from the same population and with similar demographic
characteristics (Table 1). For Sample One, the lean were plated
first followed by the obese, while for Sample Two the samples
were balanced ensuring equal allocation of the lean/obese status,
census region and age group (Figure 1). Given the small sample
sizes, a balanced design is more appropriate than a randomization
scheme employed by Harper et al. (2013). Simple randomization
is known to lead to imbalanced group sizes or clustering in small
studies. Lachin et al. (1988) showed that for small studies (i.e.,
n < 100 overall or within any principal group), imbalances that
might affect power are more likely with complete or simple ran-
domization. Balanced designs discovered by William S. Gosset
aka “Student” on the other hand are known to be more power-
ful and hence are more efficient than randomized designs (Ziliak,
2014). A balanced design tries to control for factors that may be
confounded with the outcome of interest hence leading to more
valid inferences than those from a completely randomized design.
Thus, a balanced design was chosen to reduce confounding of the
chip and row batch effects with the outcome variable of interest
(lean/obese status) which was evident in Sample One.
Although we did our best to adjust for chip- and row-
specific batch effects from both datasets, ComBat was not able to
remove chip-specific batch effects from the unbalanced Sample
One. Moreover, the number of differentially methylated probes
between the obese and lean (Table 2) increased from 5% (Pre-
ComBat) to 20% (Post-ComBat) in Sample One compared to 0%
in Sample Two (both Pre- and Post- ComBat). It seems unlikely
that the slight demographic differences between Sample One and
Sample Two (Table 1) would lead to such a dramatic difference
in the number of differentially methylated probes. In addition,
since normalization by itself cannot remove batch effects, we
would expect to see similar results even if we tried a different
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FIGURE 9 | Principal Component Analysis shows that ComBat
effectively removed the row effect but not the chip effect in
Sample One (unbalanced); however, it effectively removed the chip
effect in Sample Two (balanced). Blue and red represent p-values <
0.05 and < 0.001, respectively. The percent variance explained by
each principal component is shown. (A) Pre-ComBat: p-values from
regression analysis. (B) Post-ComBat: p-values from regression
analysis.
Table 2 | Differential methylation analysis results.
Sample One Sample Two
Pre- Post- Pre- Post-
ComBat ComBat ComBat ComBat
Total CpGs sites tested 469,507 469,507 469,328 469,328
Number of sites identified at
q-value threshold of 0.05 25,650 94,191 0 0
<Bonferroni threshold 1.06 × 10−7 369 3,660 0 0
normalization scheme. It is likely that the dramatic differences
seen in Table 2 are caused by batch effects and that the results
from Sample One are unreliable. While it is beyond the scope
of this current work, it would be of interest to directly measure
methylation using other technologies to confirm that these differ-
ences are the results of batch effects. Alternatively, similar to what
Harper et al. (2013) have done, one could run the same samples
twice, once with an unbalanced design and once with a balanced
design.
Even with these batch effects we still may be able to make
genetic inferences from these data. For instance, Spielman and
Cheung (2007), in their response to Akey et al. (2007), noted
that if we can find a genetic marker that determines the
level of methylation, then we should see differential methyla-
tion between the case and control groups when stratified by
genotype. That is, a batch effect should apply to everyone,
even within each genotype sub-group, enabling us to distin-
guish between batch effects and genetic effects on methylation
levels.
CONCLUSION
Our results illustrate that experimental design is crucial in guard-
ing against batch effects in 450K methylation arrays. When the
variables of interest are confounded with batch effects, it is
very difficult to separate them using sophisticated and care-
ful statistical analysis. Although our results agree with those
of Harper et al. (2013) who found a reduced number of sig-
nificant probes when they randomized their samples on the
chips, our design of balancing samples across the chips and
rows is more optimal than randomization given the small sam-
ple size. Our design removes any clustering that could again
confound results, which is more likely with the randomiza-
tion scheme employed by Harper et al. (2013). In general,
adjusting for batch effects using ComBat leads to improved agree-
ment between technical replicates, and an increased number
of differentially methylated sites (DMPs) (Harper et al., 2013).
However, these DMPs should be taken with caution if the samples
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are not balanced across the chips by the variable of interest
and any other variables that could easily confound the final
results.
Our results imply that great care should be taken when design-
ing a study so as to guard against possible batch effects. While this
need has been prominently discussed previously (e.g., Leek et al.,
2010), we must be ever vigilant to ensure good communication
between the statistical members of the research team and the lab-
oratory running the methylation arrays. Batch effects can not
only lead to false positive signals, but, if not corrected for ade-
quately, could obscure important true positive signals (Baggerly
et al., 2004; Akey et al., 2007; Leek and Storey, 2007; Harper et al.,
2013). As Light et al. (1990) wrote: “You can’t fix by analysis what
you bungled by design.”
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